{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:05:03Z","timestamp":1788825903504,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2-3","license":[{"start":{"date-parts":[[2016,4,23]],"date-time":"2016-04-23T00:00:00Z","timestamp":1461369600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Microenvironment"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s12307-016-0184-3","type":"journal-article","created":{"date-parts":[[2016,4,23]],"date-time":"2016-04-23T02:16:04Z","timestamp":1461377764000},"page":"77-84","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Potential Role of TRAIL in Metastasis of Mutant KRAS Expressing Lung Adenocarcinoma"],"prefix":"10.1007","volume":"9","author":[{"given":"Shyama","family":"Pal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prayag J.","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. B.","family":"Sainis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavani S.","family":"Shankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,23]]},"reference":[{"key":"184_CR1","doi-asserted-by":"publisher","first-page":"7466","DOI":"10.1158\/0008-5472.CAN-06-11912","volume":"66","author":"M Raponi","year":"2006","unstructured":"Raponi M, Zhang Y, Yu J, et al. (2006) Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung. Cancer Res 66:7466\u20137472. doi: 10.1158\/0008-5472.CAN-06-11912","journal-title":"Cancer Res"},{"key":"184_CR2","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1111\/j.1349-7006.2009.01321.x","volume":"100","author":"M Jin","year":"2009","unstructured":"Jin M, Kawakami K, Fukui Y, et al. (2009) Different histological types of non-small cell lung cancer have distinct folate and DNA methylation levels. Cancer Sci 100:2325\u20132330. doi: 10.1111\/j.1349-7006.2009.01321.x","journal-title":"Cancer Sci"},{"key":"184_CR3","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.cllc.2013.04.010","volume":"14","author":"M Skrzypski","year":"2013","unstructured":"Skrzypski M, Dziadziuszko R, Jassem E, et al. (2013) Main histologic types of non-small-cell lung cancer differ in expression of prognosis-related genes. Clin Lung Cancer 14:666\u2013673.e2. doi: 10.1016\/j.cllc.2013.04.010","journal-title":"Clin Lung Cancer"},{"key":"184_CR4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.drup.2009.11.001","volume":"13","author":"JH Stegehuis","year":"2010","unstructured":"Stegehuis JH, de Wilt LH, de Vries EG, et al. (2010) TRAIL receptor targeting therapies for non-small cell lung cancer: current status and perspectives. Drug Resist Updat Rev Comment Antimicrob Anticancer Chemother 13:2\u201315. doi: 10.1016\/j.drup.2009.11.001","journal-title":"Drug Resist Updat Rev Comment Antimicrob Anticancer Chemother"},{"key":"184_CR5","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1002\/ijc.22495","volume":"120","author":"M Garofalo","year":"2007","unstructured":"Garofalo M, Romano G, Quintavalle C, et al. (2007) Selective inhibition of PED protein expression sensitizes B-cell chronic lymphocytic leukaemia cells to TRAIL-induced apoptosis. Int J Cancer 120:1215\u20131222. doi: 10.1002\/ijc.22495","journal-title":"Int J Cancer"},{"key":"184_CR6","doi-asserted-by":"publisher","first-page":"3845","DOI":"10.1038\/onc.2008.6","volume":"27","author":"M Garofalo","year":"2008","unstructured":"Garofalo M, Quintavalle C, Di Leva G, et al. (2008) MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer. Oncogene 27:3845\u20133855. doi: 10.1038\/onc.2008.6","journal-title":"Oncogene"},{"key":"184_CR7","doi-asserted-by":"publisher","first-page":"E3355","DOI":"10.1073\/pnas.1504630112","volume":"112","author":"Y-J Jeon","year":"2015","unstructured":"Jeon Y-J, Middleton J, Kim T, et al. (2015) A set of NF-\u03baB-regulated microRNAs induces acquired TRAIL resistance in lung cancer. Proc Natl Acad Sci U S A 112:E3355\u2013E3364. doi: 10.1073\/pnas.1504630112","journal-title":"Proc Natl Acad Sci U S A"},{"key":"184_CR8","doi-asserted-by":"crossref","first-page":"4959","DOI":"10.18632\/oncotarget.2067","volume":"5","author":"N Liu","year":"2014","unstructured":"Liu N, Zuo C, Wang X, et al. (2014) miR-942 decreases TRAIL-induced apoptosis through ISG12a downregulation and is regulated by AKT. Oncotarget 5:4959\u20134971","journal-title":"Oncotarget"},{"key":"184_CR9","first-page":"3397","volume":"9","author":"DCJ Spierings","year":"2003","unstructured":"Spierings DCJ, de Vries EGE, Timens W, et al. (2003) Expression of TRAIL and TRAIL death receptors in stage III non-small cell lung cancer tumors. Clin Cancer Res Off J Am Assoc Cancer Res 9:3397\u20133405","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"184_CR10","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, et al. (2012) The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2:401\u2013404. doi: 10.1158\/2159-8290.CD-12-0095","journal-title":"Cancer Discov"},{"key":"184_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1476-5586(04)80047-2","volume":"6","author":"DR Rhodes","year":"2004","unstructured":"Rhodes DR, Yu J, Shanker K, et al. (2004) ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 6:1\u20136","journal-title":"Neoplasia"},{"key":"184_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0082241","volume":"8","author":"B Gy\u0151rffy","year":"2013","unstructured":"Gy\u0151rffy B, Surowiak P, Budczies J, L\u00e1nczky A (2013) Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer. PLoS One 8:e82241. doi: 10.1371\/journal.pone.0082241","journal-title":"PLoS One"},{"key":"184_CR13","doi-asserted-by":"publisher","first-page":"R100","DOI":"10.1186\/gb-2006-7-10-r100","volume":"7","author":"AE Carpenter","year":"2006","unstructured":"Carpenter AE, Jones TR, Lamprecht MR, et al. (2006) CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol 7:R100. doi: 10.1186\/gb-2006-7-10-r100","journal-title":"Genome Biol"},{"key":"184_CR14","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1053\/j.gastro.2010.02.046","volume":"138","author":"FJH Hoogwater","year":"2010","unstructured":"Hoogwater FJH, Nijkamp MW, Smakman N, et al. (2010) Oncogenic K-Ras turns death receptors into metastasis-promoting receptors in human and mouse colorectal cancer cells. Gastroenterology 138:2357\u20132367. doi: 10.1053\/j.gastro.2010.02.046","journal-title":"Gastroenterology"},{"key":"184_CR15","doi-asserted-by":"publisher","first-page":"5476","DOI":"10.2174\/092986711798194388","volume":"18","author":"F Wei","year":"2011","unstructured":"Wei F, Yan J, Tang D (2011) Extracellular signal-regulated kinases modulate DNA damage response - a contributing factor to using MEK inhibitors in cancer therapy. Curr Med Chem 18:5476\u20135482. doi: 10.2174\/092986711798194388","journal-title":"Curr Med Chem"},{"key":"184_CR16","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/cdd.2014.81","volume":"21","author":"J Lemke","year":"2014","unstructured":"Lemke J, von Karstedt S, Zinngrebe J, Walczak H (2014) Getting TRAIL back on track for cancer therapy. Cell Death Differ 21:1350\u20131364. doi: 10.1038\/cdd.2014.81","journal-title":"Cell Death Differ"},{"key":"184_CR17","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.molcel.2011.06.011","volume":"43","author":"M Feoktistova","year":"2011","unstructured":"Feoktistova M, Geserick P, Kellert B, et al. (2011) cIAPs block Ripoptosome formation, a RIP1\/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms. Mol Cell 43:449\u2013463. doi: 10.1016\/j.molcel.2011.06.011","journal-title":"Mol Cell"},{"key":"184_CR18","doi-asserted-by":"publisher","first-page":"3757","DOI":"10.1038\/sj.onc.1204504","volume":"20","author":"A Munshi","year":"2001","unstructured":"Munshi A, Pappas G, Honda T, et al. (2001) TRAIL (APO-2\u00a0L) induces apoptosis in human prostate cancer cells that is inhibitable by Bcl-2. Oncogene 20:3757\u20133765. doi: 10.1038\/sj.onc.1204504","journal-title":"Oncogene"},{"key":"184_CR19","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1006\/bbrc.2002.6452","volume":"291","author":"S-Y Park","year":"2002","unstructured":"Park S-Y, Billiar TR, Seol D-W (2002) IFN-gamma inhibition of TRAIL-induced IAP-2 upregulation, a possible mechanism of IFN-gamma-enhanced TRAIL-induced apoptosis. Biochem Biophys Res Commun 291:233\u2013236. doi: 10.1006\/bbrc.2002.6452","journal-title":"Biochem Biophys Res Commun"},{"key":"184_CR20","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/nm0302-274","volume":"8","author":"H LeBlanc","year":"2002","unstructured":"LeBlanc H, Lawrence D, Varfolomeev E, et al. (2002) Tumor-cell resistance to death receptor\u2013induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax. Nat Med 8:274\u2013281. doi: 10.1038\/nm0302-274","journal-title":"Nat Med"},{"key":"184_CR21","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1038\/cdd.2013.28","volume":"20","author":"K Azijli","year":"2013","unstructured":"Azijli K, Weyhenmeyer B, Peters GJ, et al. (2013) Non-canonical kinase signaling by the death ligand TRAIL in cancer cells: discord in the death receptor family. Cell Death Differ 20:858\u2013868. doi: 10.1038\/cdd.2013.28","journal-title":"Cell Death Differ"},{"key":"184_CR22","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.ccell.2015.02.014","volume":"27","author":"S Karstedt von","year":"2015","unstructured":"von Karstedt S, Conti A, Nobis M, et al. (2015) Cancer cell-autonomous TRAIL-R Signaling promotes KRAS-driven cancer progression, invasion, and metastasis. Cancer Cell 27:561\u2013573. doi: 10.1016\/j.ccell.2015.02.014","journal-title":"Cancer Cell"},{"key":"184_CR23","doi-asserted-by":"publisher","first-page":"21164","DOI":"10.1074\/jbc.M110.207571","volume":"286","author":"Z Li","year":"2011","unstructured":"Li Z, Xu X, Bai L, et al. (2011) Epidermal growth factor receptor-mediated tissue transglutaminase overexpression couples acquired tumor necrosis factor-related apoptosis-inducing ligand resistance and migration through c-FLIP and MMP-9 proteins in lung cancer cells. J Biol Chem 286:21164\u201321172. doi: 10.1074\/jbc.M110.207571","journal-title":"J Biol Chem"},{"key":"184_CR24","doi-asserted-by":"publisher","first-page":"4651","DOI":"10.1242\/jcs.109587","volume":"125","author":"K Azijli","year":"2012","unstructured":"Azijli K, Yuvaraj S, Peppelenbosch MP, et al. (2012) Kinome profiling of non-canonical TRAIL signaling reveals RIP1-Src-STAT3-dependent invasion in resistant non-small cell lung cancer cells. J Cell Sci 125:4651\u20134661. doi: 10.1242\/jcs.109587","journal-title":"J Cell Sci"},{"key":"184_CR25","doi-asserted-by":"publisher","first-page":"7434","DOI":"10.1038\/sj.onc.1209719","volume":"25","author":"A Trauzold","year":"2006","unstructured":"Trauzold A, Siegmund D, Schniewind B, et al. (2006) TRAIL promotes metastasis of human pancreatic ductal adenocarcinoma. Oncogene 25:7434\u20137439. doi: 10.1038\/sj.onc.1209719","journal-title":"Oncogene"},{"key":"184_CR26","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/nrc2228","volume":"7","author":"C L\u00f3pez-Ot\u00edn","year":"2007","unstructured":"L\u00f3pez-Ot\u00edn C, Matrisian LM (2007) Emerging roles of proteases in tumour suppression. Nat Rev Cancer 7:800\u2013808. doi: 10.1038\/nrc2228","journal-title":"Nat Rev Cancer"}],"container-title":["Cancer Microenvironment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12307-016-0184-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12307-016-0184-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12307-016-0184-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12307-016-0184-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T07:50:11Z","timestamp":1559461811000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12307-016-0184-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,23]]},"references-count":26,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["184"],"URL":"https:\/\/doi.org\/10.1007\/s12307-016-0184-3","relation":{},"ISSN":["1875-2292","1875-2284"],"issn-type":[{"value":"1875-2292","type":"print"},{"value":"1875-2284","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,23]]}}}